|
IL112372A
(en)
|
1994-02-07 |
2001-08-26 |
Res Dev Foundation |
Non-viral vector for the delivery of genetic information to cells
|
|
DE69628418T2
(de)
|
1995-03-22 |
2004-04-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
|
ATE348887T1
(de)
|
1996-10-31 |
2007-01-15 |
Human Genome Sciences Inc |
Streptococcus pneumoniae antigene und impfstoffe
|
|
ES2230687T3
(es)
|
1997-04-24 |
2005-05-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Copulacion de proteinas nomodificadas con polisacaridos derivados de haloacilo o de dihaloacilo para la preparacion de vacunas que incluyen proteinas-polisacaridos.
|
|
US7060458B1
(en)
|
1997-08-14 |
2006-06-13 |
Wyeth |
Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
|
|
WO1999012416A1
(en)
|
1997-09-09 |
1999-03-18 |
The Trustees Of Columbia University In The City Of New York |
T-independent conjugate-vaccines
|
|
EP1144640A3
(en)
|
1998-07-27 |
2001-11-28 |
Microbial Technics Limited |
Nucleic acids and proteins from streptococcus pneumoniae
|
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
NZ536859A
(en)
|
2002-05-14 |
2007-11-30 |
Chiron Srl |
Mucosal combination vaccines for bacterial meningitis
|
|
EP1603950A2
(en)
|
2003-03-17 |
2005-12-14 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
US7635487B2
(en)
|
2003-04-15 |
2009-12-22 |
Intercell Ag |
S. pneumoniae antigens
|
|
WO2005004909A2
(en)
|
2003-05-07 |
2005-01-20 |
Aventis Pasteur, Inc. |
Method of enhanced immunogenicity to meningococcal vaccination
|
|
WO2005037190A2
(en)
|
2003-09-03 |
2005-04-28 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
|
US20050214318A1
(en)
|
2003-10-23 |
2005-09-29 |
Nmk Research, Llc |
Immunogenic composition and method of developing a vaccine based on fusion protein
|
|
EP1740604A2
(en)
|
2004-04-27 |
2007-01-10 |
Intercell AG |
Td antigens
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
JP2008509682A
(ja)
|
2004-08-18 |
2008-04-03 |
ガヴァナーズ オブ ザ ユニヴァーシティー オブ アルバータ |
Ｙｅｂｆを利用するタンパク質の製造方法
|
|
FI20041396A0
(fi)
|
2004-10-29 |
2004-10-29 |
Vesa Pekka Hytoenen |
Uudet mikrobiavidiinit
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
CA2597489A1
(en)
|
2005-02-11 |
2006-08-17 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides
|
|
US20090148894A1
(en)
|
2005-08-15 |
2009-06-11 |
Broedel Sheldon E |
Methods for optimizing the secretion of protein in prokaryotes
|
|
CN102973929B
(zh)
|
2005-09-01 |
2017-04-26 |
诺华疫苗和诊断有限两合公司 |
含血清群c脑膜炎球菌的多价疫苗
|
|
WO2007062037A2
(en)
*
|
2005-11-21 |
2007-05-31 |
Laboratoires Serono Sa |
Compositions and methods of producing hybrid antigen binding molecules and uses thereof
|
|
EP1973572A2
(en)
|
2005-12-08 |
2008-10-01 |
University of Louisville Research Foundation, Inc. |
In vivo cell surface engineering
|
|
WO2007081583A2
(en)
|
2006-01-04 |
2007-07-19 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations and methods of use
|
|
US7943133B2
(en)
|
2006-02-02 |
2011-05-17 |
Boston Biocom Llc |
Mesothelin antibody protein fusions and methods of use
|
|
US20080032340A1
(en)
|
2006-06-09 |
2008-02-07 |
University Of Arizona |
Peptide motifs for binding avidin or neutravidin
|
|
US8148084B2
(en)
|
2006-06-22 |
2012-04-03 |
Dana-Farber Cancer Institute, Inc. |
Diagnosis of autoimmune disease
|
|
WO2007150020A1
(en)
|
2006-06-23 |
2007-12-27 |
Simon Paul M |
Targeted immune conjugates
|
|
US7452985B2
(en)
|
2006-08-17 |
2008-11-18 |
Visgeneer, Inc. |
Human Ron-related gene variant associated with cancers
|
|
EP2104512A2
(en)
|
2006-12-21 |
2009-09-30 |
Emergent Product Development UK Limited |
Streptococcus proteins, and their use in vaccination
|
|
CN100579152C
(zh)
|
2007-01-29 |
2010-01-06 |
华为技术有限公司 |
一种播放集团彩铃的方法、系统及装置
|
|
KR101491867B1
(ko)
|
2007-01-31 |
2015-02-10 |
피페넥스 인크. |
증가된 발현을 위한 박테리아 리더 서열
|
|
AU2008287286B2
(en)
|
2007-04-13 |
2013-10-10 |
The Board Of Regents Of The University Of Oklahoma |
Mutants of cholesterol-dependent cytolysins and uses thereof
|
|
EA200901578A1
(ru)
|
2007-06-26 |
2010-08-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
WO2009021548A1
(en)
|
2007-08-10 |
2009-02-19 |
Wacker Chemie Ag |
Expression of full length igg and secretion into the culture medium of prokaryotic cells
|
|
KR20100072228A
(ko)
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
CN106008679A
(zh)
|
2008-12-24 |
2016-10-12 |
荷兰王国卫生福利和运动部国家公共卫生和环境研究所 |
修饰的肺炎链球菌溶血素(ply)多肽
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
EP2419129A2
(en)
|
2009-04-14 |
2012-02-22 |
Novartis AG |
Compositions for immunising against staphylococcus aerus
|
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
JP5931724B2
(ja)
|
2009-06-29 |
2016-06-08 |
ジェノセア バイオサイエンシーズ， インコーポレイテッド |
ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物
|
|
CN101797381B
(zh)
|
2010-01-29 |
2012-05-23 |
中国人民解放军第三军医大学 |
乙肝病毒抗原与路易斯寡糖的复合物及其制备方法和应用
|
|
US20130115230A1
(en)
|
2010-04-30 |
2013-05-09 |
Augmenta Biologicals, Llc |
Delivery proteins
|
|
RU2632651C2
(ru)
*
|
2011-05-11 |
2017-10-06 |
Чилдрен'С Медикал Сентер Корпорейшн |
Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение
|
|
WO2014018904A1
(en)
*
|
2012-07-26 |
2014-01-30 |
Genocea Biosciences, Inc. |
Fused antigen vaccines and compositions against streptococcus pneumoniae
|
|
EP4272750A3
(en)
*
|
2013-02-07 |
2024-01-24 |
Children's Medical Center, Corp. |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
|
JP2019524639A
(ja)
|
2016-05-04 |
2019-09-05 |
ザ チルドレンズ メディカル センター コーポレーション |
アビジン様タンパク質およびそれらの融合タンパク質を精製する方法
|
|
EP3600400A4
(en)
|
2017-03-28 |
2021-01-13 |
The Children's Medical Center Corporation |
MULTIPLE ANTIGEN (MAPS) BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGENIC COMPOSITION AND USES THEREOF
|
|
CN112969474A
(zh)
*
|
2018-09-12 |
2021-06-15 |
艾芬尼维克斯公司 |
多价肺炎球菌疫苗
|